Berlin-based Kyrok, which is building an AI operating system for pharmaceutical and chemical supply chains, has secured €3.1 million in pre-seed funding from Speedinvest, with support from Arve Capital and other industry and tech investors.
- Founded in 2025 by Daniel Hofinger and Lukas Bierfreund, Kyrok develops an AI operating system for supply chain management in mid-sized pharmaceutical and chemical companies.
- The platform sits on top of existing ERP systems and connects fragmented workflows across customer service, production planning, material planning, and procurement into a single interface.
- It uses AI agents to assist with routine tasks such as order processing and data handling, while employees remain responsible for final decisions.
- By capturing operational knowledge that is often spread across spreadsheets and individual experience, the system aims to reduce manual work, improve accuracy, and make processes less dependent on specific employees, particularly in industries facing ageing workforces and legacy software.
Details of the deal
- The €3.1 million round will be used to develop Kyrok’s platform further, expand its supply chain modules beyond customer service, and scale the product across more pharmaceutical and chemical SMEs while growing the team in Berlin.
“Daniel and Lukas have already shown that they can make industrial companies more competitive through technology. With Kyrok, they are modernising an entire sector without taking it offline to do it. That is exactly the kind of leverage Europe needs to keep its SMEs competitive and its pharma and chemical supply chains resilient,” explains Florian Obst, Partner at Speedinvest.
